| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 活性原料(元) | 26,163,731.05 | 30,618,304.13 | 391,906,730.81 | 280,709,984.81 |
| 技术服务收入(元) | - | - | - | 1,073,627.56 |
| 疫苗(元) | 3,960,126,056.91 | 3,387,077,070.32 | 8,492,556,779.84 | 4,363,385,481.71 |
| 诊断试剂(元) | - | 679,518,710.87 | - | 1,185,420,262.73 |
| 诊断仪器(元) | - | 18,019,573.48 | - | 17,688,495.08 |
| 代理产品(元) | 114,987,771.07 | 34,839,173.20 | 145,470,989.59 | 74,989,268.16 |
| 试剂(元) | 1,331,266,307.12 | - | 2,085,398,682.19 | - |
| 仪器(元) | 60,936,821.67 | - | 51,339,224.00 | - |
| 其他主营业务(元) | - | - | - | 74,989,268.16 |
| 其他业务(元) | - | - | - | 6,460,438.41 |
| 营业成本(元) | ||||
| 活性原料(元) | 4,064,701.44 | - | 15,692,786.98 | - |
| 技术服务收入(元) | - | - | - | - |
| 疫苗(元) | 332,564,649.09 | 203,687,904.24 | 518,537,306.07 | 277,493,381.72 |
| 诊断试剂(元) | - | - | - | - |
| 诊断仪器(元) | - | - | - | - |
| 代理产品(元) | 63,190,599.31 | - | 73,176,815.52 | - |
| 试剂(元) | 302,930,117.26 | - | 491,761,183.01 | - |
| 仪器(元) | 84,111,146.08 | - | 65,483,690.17 | - |
| 其他主营业务(元) | - | - | - | - |
| 其他业务(元) | - | - | - | 1,214,749.88 |
| 毛利(元) | ||||
| 活性原料(元) | 22,099,029.61 | - | 376,213,943.83 | - |
| 技术服务收入(元) | - | - | - | - |
| 疫苗(元) | 3,627,561,407.82 | 3,183,389,166.08 | 7,974,019,473.77 | 4,085,892,099.99 |
| 诊断试剂(元) | - | - | - | - |
| 诊断仪器(元) | - | - | - | - |
| 代理产品(元) | 51,797,171.76 | - | 72,294,174.07 | - |
| 试剂(元) | 1,028,336,189.86 | - | 1,593,637,499.18 | - |
| 仪器(元) | -23,174,324.41 | - | -14,144,466.17 | - |
| 其他主营业务(元) | - | - | - | - |
| 其他业务(元) | - | - | - | 5,245,688.53 |
| 毛利率(%) | ||||
| 活性原料(%) | 84.46 | - | 96.00 | - |
| 技术服务收入(%) | - | - | - | - |
| 疫苗(%) | 91.60 | 93.99 | 93.89 | 93.64 |
| 诊断试剂(%) | - | - | - | - |
| 诊断仪器(%) | - | - | - | - |
| 代理产品(%) | 45.05 | - | 49.70 | - |
| 试剂(%) | 77.24 | - | 76.42 | - |
| 仪器(%) | -38.03 | - | -27.55 | - |
| 其他主营业务(%) | - | - | - | - |
| 其他业务(%) | - | - | - | 81.20 |
| 收入构成(%) | ||||
| 活性原料(%) | 0.48 | 0.74 | 3.51 | 4.67 |
| 技术服务收入(%) | - | - | - | 0.02 |
| 疫苗(%) | 72.09 | 81.61 | 76.05 | 72.67 |
| 诊断试剂(%) | - | 16.37 | - | 19.74 |
| 诊断仪器(%) | - | 0.43 | - | 0.29 |
| 代理产品(%) | 2.09 | 0.84 | 1.30 | 1.25 |
| 试剂(%) | 24.23 | - | 18.68 | - |
| 仪器(%) | 1.11 | - | 0.46 | - |
| 其他主营业务(%) | - | - | - | 1.25 |
| 其他业务(%) | - | - | - | 0.11 |
| 毛利构成(%) | ||||
| 活性原料(%) | 0.47 | 0.00 | 3.76 | 0.00 |
| 技术服务收入(%) | - | - | - | 0.00 |
| 疫苗(%) | 77.07 | 100.00 | 79.72 | 99.87 |
| 诊断试剂(%) | - | 0.00 | - | 0.00 |
| 诊断仪器(%) | - | 0.00 | - | 0.00 |
| 代理产品(%) | 1.10 | 0.00 | 0.72 | 0.00 |
| 试剂(%) | 21.85 | - | 15.93 | - |
| 仪器(%) | -0.49 | - | -0.14 | - |
| 其他主营业务(%) | - | - | - | 0.00 |
| 其他业务(%) | - | - | - | 0.13 |